Article Versions Notes

Yokoyama Y, Morimoto Y, Yamamoto H, Kouda S, Kawanami S, Yang R, Zhang Y, Tsujimoto M, Nagata N, Shimomura Y, et al. Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights. Cancers. 2026; 18(7):1104. https://doi.org/10.3390/cancers18071104

Yokoyama, Yuhki, Yoshihiro Morimoto, Hiroyuki Yamamoto, Shihori Kouda, Shiho Kawanami, Ruijia Yang, Yingjue Zhang, Manami Tsujimoto, Nanami Nagata, Yuki Shimomura, and et al. 2026. "Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights" Cancers 18, no. 7: 1104. https://doi.org/10.3390/cancers18071104

Yokoyama, Y., Morimoto, Y., Yamamoto, H., Kouda, S., Kawanami, S., Yang, R., Zhang, Y., Tsujimoto, M., Nagata, N., Shimomura, Y., Nishida, K., Hata, T., Inoue, A., Shibata, S., Yamamoto, H., & Mori, M. (2026). Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights. Cancers, 18(7), 1104. https://doi.org/10.3390/cancers18071104